SCHEMBL8829396

SCHEMBL8829396

CS(=O)(=O)NC(=O)c1cccc(CC2CCc3ccc(OCc4nc5cc(F)ccc5s4)cc3C2O)c1

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYSLTR1 Q9Y271 8/20 0.60
CYSLTR2 Q9NS75 7/20 0.60
PTGER4 P35408 2/20 0.48
ALOX5 P09917 3/20 0.38
CYP4F2 P78329 1/20 0.38
CYP4A11 Q02928 1/20 0.38
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
RAB9A P51151 1/20 0.37
MDM2 Q00987 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
SCN9A Q15858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8829399 1.00 CYSLTR1 (0.60) CYSLTR1CYSLTR2PTGER4ALOX5CYP4F2
SCHEMBL9146513 1.00 CYSLTR1 (0.60) CYSLTR1CYSLTR2PTGER4ALOX5CYP4F2
SCHEMBL8829469 0.89 CYSLTR1 (0.69) CYSLTR1CYSLTR2PTGER4ALOX5CYP4F2
SCHEMBL8829475 0.89 CYSLTR1 (0.69) CYSLTR1CYSLTR2PTGER4ALOX5CYP4F2
SCHEMBL8829472 0.89 CYSLTR1 (0.69) CYSLTR1CYSLTR2PTGER4ALOX5CYP4F2
SCHEMBL8829375 0.87 CYSLTR1 (0.80) CYSLTR1CYSLTR2PTGER4
SCHEMBL8829374 0.87 CYSLTR1 (0.80) CYSLTR1CYSLTR2PTGER4
SCHEMBL8829409 0.87 CYSLTR1 (0.80) CYSLTR1CYSLTR2PTGER4
SCHEMBL8829459 0.85 CYSLTR1 (0.61) CYSLTR1CYSLTR2PTGER4ALOX5
SCHEMBL8829460 0.85 CYSLTR1 (0.61) CYSLTR1CYSLTR2PTGER4ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0404440-B1 Substituted sulfonamides and related compounds in the treatment of asthma, arthritis, and related diseases PFIZER (US) 1997-11-05 EP disclosed
US-5384318-A Substituted sulfonamides and related compounds in the treatment of asthma, arthritis and related diseases PFIZER INC. (US) 1995-01-24 US disclosed
EP-0404440-A2 Substituted sulfonamides and related compounds in the treatment of asthma, arthritis, and related diseases PFIZER INC. (US) 1990-12-27 EP disclosed
WO-1990015801-A1 SUBSTITUTED SULFONAMIDES AND RELATED COMPOUNDS IN THE TREATMENT OF ASTHMA, ARTHRITIS AND RELATED DISEASES PFIZER INC. (US) 1990-12-27 WO disclosed